HCPCS J2795: Ropivacaine Hydrochloride Injection, 1 mg

HCPCS Level II code J2795 denotes injection of ropivacaine hydrochloride, 1 mg, a commonly used local anesthetic for regional blocks and procedural pain control. Nationally, accurate coding for injectable anesthetics is important for clinical documentation, appropriate reimbursement, and monitoring of medication utilization in surgical and pain-management settings. This code matters where ropivacaine is used as an alternative to other local anesthetics due to its clinical profile.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context and service implications, plus an overview of typical sites of service. The publication outlines benchmarks and payer coverage patterns where available, highlights relevant policy considerations affecting billing for injectable local anesthetics, and summarizes documentation and claim submission issues commonly encountered with HCPCS Level II drug codes. Data not available in the input will be noted explicitly where applicable.

Billing Code Overview

HCPCS Level II code J2795 represents an injection of ropivacaine hydrochloride, dosed at 1 mg per unit. This code is used to report administration of the local anesthetic agent ropivacaine for procedures requiring regional or local anesthesia.

Service Type: Medication administration (injectable local anesthetic)

Typical Site of Service: Hospital outpatient departments, ambulatory surgery centers, physician offices, and other settings where injectable local anesthetics are administered for procedural anesthesia or pain management

Data not available in the input.

Clinical Context

A typical patient is a 54-year-old undergoing outpatient regional anesthesia for an orthopedic procedure (e.g., ankle ORIF or rotator cuff repair) or an interventional pain management procedure (e.g., peripheral nerve block or catheter infusion) who receives an injection of J2795 (ropivacaine hydrochloride, 1 mg). The clinical workflow: pre-procedure evaluation in the pre-op or procedural suite with informed consent and allergy check; verification of site and laterality; ultrasound or nerve stimulator localization of the target nerve or plexus; sterile preparation and local skin anesthesia; administration of calculated dose of ropivacaine using J2795 for single-shot peripheral nerve block or as part of an indwelling catheter bolus; post-procedure monitoring for block efficacy and adverse effects (vital signs, motor/sensory checks); documentation of drug name, concentration, volume, lot number, route, site, and any immediate complications. Typical sites of service include ambulatory surgery centers, hospital outpatient departments, and pain clinics. Patient scenarios include perioperative analgesia for limb surgery, acute pain control for trauma-related fractures, or chronic neuropathic pain requiring diagnostic or therapeutic blockades. Common clinical considerations include dose calculation by weight, avoidance in patients with local anesthetic allergy, and monitoring for systemic toxicity.

Coding Specifications

Modifier	Description	When to Use
`59`

Taxonomy Code	Specialty	Notes
`207P00000X`	Anesthesiology	Anesthesiologists commonly perform peripheral nerve blocks and perioperative regional anesthesia using ropivacaine.
`208500000X`	Pain Medicine	Interventional pain management physicians perform diagnostic and therapeutic nerve blocks and injections.
`207L00000X`	Surgery - Orthopedic	Orthopedic surgeons often coordinate or perform regional blocks for limb surgeries in perioperative settings.
`163W00000X`	Physical Medicine & Rehabilitation	PM&R physicians may perform diagnostic nerve blocks in chronic pain management.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M25.571`	Pain in right ankle and joints of right foot	Peripheral nerve blocks with ropivacaine may be used for analgesia in ankle procedures or acute pain.
`S82.101A`	Unspecified fracture of right tibia, initial encounter for closed fracture	Acute fractures of the lower extremity often receive regional blocks for operative fixation and pain control.
`M75.10`	Adhesive capsulitis of unspecified shoulder	Diagnostic or therapeutic shoulder region blocks may be performed using ropivacaine.
`G89.18`	Other acute postprocedural pain	Ropivacaine used for perioperative or postprocedural analgesia when significant acute pain is present.
`M54.5`	Low back pain	Facet or lumbar plexus related blocks may use ropivacaine for diagnostic or therapeutic relief.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`64450`	Injection, anesthetic agent; other peripheral nerve or branch	Used for single-shot peripheral nerve block procedures where ropivacaine (`J2795`) is the local anesthetic administered.
`64483`	Injection, anesthetic agent; sciatic nerve, single	Commonly performed for lower extremity surgeries where ropivacaine provides surgical and postoperative analgesia.
`64490`	Injection, anesthetic agent; brachial plexus, single injection	Performed for upper extremity procedures; ropivacaine is used for prolonged sensory block.
`36556`	Insertion of non-tunneled centrally inserted central venous catheter (CVC) (for reference to infusion setups)	When indwelling catheters are placed for continuous local anesthetic infusions, ropivacaine boluses may be administered via catheter.
`01996`	Continuous regional anesthesia infusion, per day (anesthesia management)	Billed for anesthesia management of continuous peripheral nerve catheter infusions where ropivacaine may be infused.

OpenPayer

Summary & Overview